QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal third quarter financial results on Thursday, April 2, 2009 after the close of the financial markets.
